LYSOGENE is a clinical stage pioneering biotechnology company in the field of gene therapy targeting severe genetic pathologies of central nervous system in children.

WEBSITE REDESIGN AND CONTENT REVIEW


We are redesigning our website and updating its contents. If you can’t find the information you’re looking for, please renew your visit or send us an e-mail so we can inform you when the new website is on-line.

 
Twitter Image
View 's profile on LinkedIn
Facebook Image
 

LAST NEWS

LYSOGENE, UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL AND AUBURN UNIVERSITY ANNOUNCE COLLABORATION AGREEMENT

 

Read more...
 
LEERINK GLOBAL HEALTHCARE CONFERENCE

Read more...
 
11th ANNUAL SYMPOSIUM OF LSD NETWORK

Read more...